Cited by 1,530Tryptophan and brain disordersAmino Acid Enzymes and MetabolismNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 213 of the 215 references it cites were found in a registry or an index.

Kynurenines in the mammalian brain: when physiology meets pathology

Open access

Schwarcz, Robert, Bruno, John P., Muchowski, Paul J., Wu, Hui-Qiu·2012·Nature Reviews Neuroscience

DOI 10.1038/nrn3257PMC PMC3681811

Open this paper in CoChat — free account

Abstract

The essential amino acid tryptophan is not only a precursor of serotonin but is also degraded to several other neuroactive compounds, including kynurenic acid, 3-hydroxykynurenine and quinolinic acid. The synthesis of these metabolites is regulated by an enzymatic cascade, known as the kynurenine pathway, that is tightly controlled by the immune system. Dysregulation of this pathway, resulting in hyper-or hypofunction of active metabolites, is associated with neurodegenerative and other neurological disorders, as well as with psychiatric diseases such as depression and schizophrenia. With recently developed pharmacological agents, it is now possible to restore metabolic equilibrium and envisage novel therapeutic interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrn3257

Cites

213 of 213 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Mammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724
Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain
Simon, R. P., Swan, J. H., Griffiths, T., & Meldrum, B. S. (1984) · Science · doi:10.1126/science.6093256 · Cited by 1,682
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate
Anis, N. A., Berry, S. C., Burton, N. R., & Lodge, D. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb11031.x · Cited by 1,399
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R. M., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,269
Self-citation
Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea
Coyle, J. T., & Schwarcz, R. M. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,255
Self-citation
Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
Lahti, A., Koffel, B., Laporte, D., & Tamminga, C. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 965

Flagged first, then by citations

Show all 215 references

2 of the 215 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 1,002

Mass spectrometry‐based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders
Luan, H., Wang, X., & Cai, Z. (2017) · Mass Spectrometry Reviews · doi:10.1002/mas.21553 · Cited by 192
Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders
Mor, A., Tankiewicz‐Kwedlo, A., Krupa, A., & Pawlak, D. (2021) · Cells · doi:10.3390/cells10071603 · Cited by 188
L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences
Fujigaki, H., Yamamoto, Y., & Saito, K. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.011 · Cited by 189
Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation
Parrott, J. M., Redus, L., Santana-Coelho, D., Morales, J., Gao, X., & O'Connor, J. C. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.200 · Cited by 174
Kynurenine pathway metabolites and suicidality
Bryleva, E. Y., & Brundin, L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.034 · Cited by 168
Physiological Roles of Non-Neuronal NMDA Receptors
Hogan-Cann, A. D., & Anderson, C. M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.012 · Cited by 183
Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk
Barron, H., Hafizi, S., Andreazza, A. C., & Mizrahi, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030651 · Cited by 183
Multitarget approach for natural products in inflammation
Jude, S., & Gopi, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819218-4.00004-3 · Cited by 176
Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder
Meier, T. B., Drevets, W. C., Wurfel, B. E., Ford, B. N., Morris, H. M., Victor, T. A., Bodurka, J., Teague, T. K., Dantzer, R., & Savitz, J. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.003 · Cited by 175
3‐hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis
LeWitt, P. A., Li, J., Lü, M., Beach, T. G., Adler, C. H., & Guo, L. (2013) · Movement Disorders · doi:10.1002/mds.25555 · Cited by 171
The link between inflammation, bugs, the intestine and the brain in alcohol dependence
Leclercq, S., de Timary, P., Delzenne, N. M., & Stärkel, P. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.15 · Cited by 174
Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression
Haroon, E., Welle, J. R., Woolwine, B. J., Goldsmith, D. R., Baer, W. M., Patel, T., Felger, J. C., & Miller, A. H. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0607-1 · Cited by 181
The Role of Tryptophan Metabolites in Neuropsychiatric Disorders
Davidson, M., Rashidi, N., Nurgali, K., & Apostolopoulos, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179968 · Cited by 182
The role of inflammation in suicidal behaviour
Brundin, L., Erhardt, S., Bryleva, E. Y., Achtyes, E. D., & Postolache, T. T. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12458 · Cited by 178
Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling
Nigám, S. K., & Bush, K. T. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0111-1 · Cited by 184
Tryptophan Metabolism and Related Pathways in Psychoneuroimmunology: The Impact of Nutrition and Lifestyle
Gostner, J. M., Geisler, S., Stonig, M., Mair, L., Sperner‐Unterweger, B., & Fuchs, D. (2019) · Neuropsychobiology · doi:10.1159/000496293 · Cited by 167
Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders
O’Farrell, K., & Harkin, A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.004 · Cited by 170
Energy Metabolism Decline in the Aging Brain—Pathogenesis of Neurodegenerative Disorders
Błaszczyk, J. W. (2020) · Metabolites · doi:10.3390/metabo10110450 · Cited by 166
Tryptophan metabolism: entering the field of aging and age-related pathologies
van der Goot, A. T., & Nollen, E. A. A. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.02.007 · Cited by 166
The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases
Morris, G., Berk, M., Gałecki, P., Walder, K. R., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9090-9 · Cited by 163
Serotonin – Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Oxenkrug, G. F. (2013) · Current Drug Targets · doi:10.2174/1389450111314050002 · Cited by 163
Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors
Lawson, M. A., Parrott, J. M., McCusker, R. H., Dantzer, R., Kelley, K. W., & O’Connor, J. C. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-87 · Cited by 166
LC–MS/MS-Based Quantification of Kynurenine Metabolites, Tryptophan, Monoamines and Neopterin in Plasma, Cerebrospinal Fluid and Brain
Fuertig, R., Ceci, A., Camus, S. M. J., Bézard, E., Luippold, A. H., & Hengerer, B. (2016) · Bioanalysis · doi:10.4155/bio-2016-0111 · Cited by 164
Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities
Savitz, J., Frank, M. B., Victor, T., Bebak, M., Marino, J. H., Bellgowan, P. S. F., McKinney, B. A., Bodurka, J., Kent Teague, T., & Drevets, W. C. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.007 · Cited by 146
Host–microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling
Ma, N., He, T., Johnston, L. J., & Ma, X. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1758008 · Cited by 162
The microbiota-gut-brain axis as a key regulator of neural function and the stress response: Implications for human and animal health
Wiley, N., Dinan, T. G., Ross, R. P., Stanton, C., Clarke, G. A., & Cryan, J. F. (2017) · Journal of Animal Science · doi:10.2527/jas.2016.1256 · Cited by 190
Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease
Sorgdrager, F. J. H., Vermeiren, Y., van Faassen, M. H. J. R., van der Ley, C., Nollen, E. A. A., Kema, I. P., & Deyn, P. P. D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14843 · Cited by 158
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites
Breda, C., Sathyasaikumar, K. V., Sograte‐Idrissi, S., Notarangelo, F. M., Estranero, J. G., Moore, G. G. L., Green, E. W., Kyriacou, C. P., Schwarcz, R. M., & Giorgini, F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604453113 · Cited by 154
Self-citation
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
Lovelace, M. D., Varney, B., Sundaram, G., Franco, N. F., Ng, M. L., Pai, S., Lim, C. K., Guillemin, G. J., & Brew, B. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00246 · Cited by 161
Short-chain fatty acids-producing probiotics: A novel source of psychobiotics
Cheng, Y., Liu, J., & Ling, Z. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1920884 · Cited by 156
Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
Haroon, E., & Miller, A. H. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_40 · Cited by 153
Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases
Reyes-Ocampo, J. G., Lugo-Huitrón, R., González‐Esquivel, D. F., Ugalde‐Muñiz, P., Jiménez‐Anguiano, A., Pineda, B., Pedraza‐Chaverrí, J., Rı́os, C., & de la Cruz, V. P. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/646909 · Cited by 149
Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes
Oxenkrug, G. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9232-0 · Cited by 151
Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders: Evidence through univariate and multivariate mega-analysis including 6420 participants from the ENIGMA MDD working group
Opel, N., Thalamuthu, A., Milaneschi, Y., Grotegerd, D., Flint, C., Leenings, R., Goltermann, J., Richter, M., Hahn, T., Woditsch, G., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0774-9 · Cited by 148
Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: Facts and challenges
Albuquerque, E. X., & Schwarcz, R. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.12.014 · Cited by 150
Self-citation
Treating the whole body in Huntington's disease
Carroll, J. B., Bates, G. P., Steffan, J. S., Carsten Saft, C., & Tabrizi, S. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00177-5 · Cited by 157
Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depression
Achtyes, E. D., Keaton, S. A., Smart, L., Burmeister, A. R., Heilman, P. L., Krzyżanowski, S., Nagalla, M., Guillemin, G. J., Galvis, M. L. E., Lim, C. K., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.10.017 · Cited by 147
The Tryptophan and Kynurenine Pathway Involved in the Development of Immune-Related Diseases
Tsuji, A., Ikeda, Y., Yoshikawa, S., Taniguchi, K., Sawamura, H., Morikawa, S., Nakashima, M., Asai, T. T., & Matsuda, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065742 · Cited by 161
Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology
Adams, S., Teo, C., McDonald, K. L., Zinger, A., Bustamante, S., Lim, C. K., Sundaram, G., Braidy, N., Brew, B. J., & Guillemin, G. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112945 · Cited by 149
Stress induced microglial activation contributes to depression
Li, B., Yang, W., Ge, T., Wang, Y., & Cui, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106145 · Cited by 151
Biomarker Research in Parkinson’s Disease Using Metabolite Profiling
Havelund, J. F., Heegaard, N. H. H., Færgeman, N. J., & Gramsbergen, J. B. (2017) · Metabolites · doi:10.3390/metabo7030042 · Cited by 147
Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers
Trippier, P. C., Labby, K. J., Hawker, D. D., Mataka, J., & Silverman, R. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3015926 · Cited by 141
3D Culture Method for Alzheimer's Disease Modeling Reveals Interleukin-4 Rescues Aβ42-Induced Loss of Human Neural Stem Cell Plasticity
Papadimitriou, C., Celikkaya, H., Cosacak, M. I., Mashkaryan, V., Bray, L., Bhattarai, P., Brandt, K., Hollak, H., Chen, X., He, S., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.06.005 · Cited by 143
Vitamin B6 and Diabetes: Relationship and Molecular Mechanisms
Mascolo, E., & Vernı̀, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103669 · Cited by 148
Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies
Giovanoli, S., Weber‐Stadlbauer, U., Schedlowski, M., Meyer, U., & Engler, H. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.09.015 · Cited by 139
LC-MS/MS-based quantification of tryptophan metabolites and neurotransmitters in the serum and brain of mice
Wang, L.-S., Zhang, M., Xue, T., Zhou, Y., Liu, X., Pan, R., Liao, Y., & Chang, Q. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.02.021 · Cited by 145
Microbes and the mind: emerging hallmarks of the gut microbiota-brain axis
Bauer, K. C., Huus, K. E., & Finlay, B. B. (2016) · Cellular Microbiology · doi:10.1111/cmi.12585 · Cited by 151
Polyamines and Kynurenines at the Intersection of Immune Modulation
Proietti, E., Rossini, S., Grohmann, U., & Mondanelli, G. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.09.007 · Cited by 146
Cytokines and the neurodevelopmental basis of mental illness
Ratnayake, U., Quinn, T., Walker, D. W., & Dickinson, H. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00180 · Cited by 141
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway
Dounay, A. B., Tuttle, J. B., & Verhoest, P. R. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00461 · Cited by 138
Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
Huang, Y., Zhao, M., Chen, X., Zhang, R., Le, A., Hong, M., Zhang, Y., Jia, L., Zang, W., Jiang, C., et al. (2023) · Aging and disease · doi:10.14336/ad.2022.0916 · Cited by 138
“KYNA inhibits endogenous broad-spectrum glutamate receptors, namely, N-methylD-aspartic acid receptors (NMDAR), kainite receptors, and α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors (AMPAR) [30].”
BackgroundInfluential
Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?
Dantzer, R., & Walker, A. K. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1187-1 · Cited by 146
Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase
Fuertig, R., Azzinnari, D., Bergamini, G., Cathomas, F., Sigrist, H., Seifritz, E., Vavassori, S., Luippold, A., Hengerer, B., Ceci, A., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.020 · Cited by 135
Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
Heilman, P. L., Wang, E. W., Lewis, M. M., Krzyżanowski, S., Capan, C. D., Burmeister, A. R., Du, G., Galvis, M. L. E., Brundin, P., Huang, X., et al. (2020) · Movement Disorders · doi:10.1002/mds.28202 · Cited by 134
Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
Suneson, K., Lindahl, J., Hårsmar, S. C., Söderberg, G., & Lindqvist, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041640 · Cited by 150
Peripheral and central kynurenine pathway abnormalities in major depression
Paul, E. R., Schwieler, L., Erhardt, S., Boda, S., Trepci, A., Kämpe, R., Asratian, A., Holm, L., Yngve, A., Dantzer, R., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.01.002 · Cited by 134
Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder
Savitz, J. B., Dantzer, R., Wurfel, B. E., Victor, T. A., Ford, B. N., Bodurka, J., Bellgowan, P. S. F., Teague, T. K., & Drevets, W. C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.11.015 · Cited by 133
The BTBR Mouse Model of Autism Spectrum Disorders Has Learning and Attentional Impairments and Alterations in Acetylcholine and Kynurenic Acid in Prefrontal Cortex
McTighe, S. M., Webb, S. J. N., Lin, Q., Hughes, Z. A., & Smith, D. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062189 · Cited by 139
Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies
Arnone, D., Saraykar, S., Salem, H., Teixeira, A. L., Dantzer, R., & Selvaraj, S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.05.031 · Cited by 139
Targeted Deletion of Kynurenine 3-Monooxygenase in Mice
Giorgini, F., Huang, S.-Y., Sathyasaikumar, K. V., Notarangelo, F. M., Thomas, M. A. R., Tararina, M. A., Wu, H., Schwarcz, R. M., & Muchowski, P. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503813 · Cited by 138
Self-citation
Structural basis of kynurenine 3-monooxygenase inhibition
Amaral, M., Levy, C., Heyes, D. J., Lafite, P., Outeiro, T. F., Giorgini, F., Leys, D., & Scrutton, N. S. (2013) · Nature · doi:10.1038/nature12039 · Cited by 134
Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease
Craig, C. F., Filippone, R. T., Stavely, R., Bornstein, J. C., Apostolopoulos, V., & Nurgali, K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02354-1 · Cited by 124
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
Doney, E., Cadoret, A., Dion‐Albert, L., Lebel, M., & Ménard, C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15239 · Cited by 134
Kynurenine emerges from the shadows – Current knowledge on its fate and function
Marszałek‐Grabska, M., Walczak, K., Gaweł, K., Wicha-Komsta, K., Wnorowska, S., Wnorowski, A., & Turski, W. A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107845 · Cited by 128
Rescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants
Borsini, A., Alboni, S., Horowitz, M. A., Tojo, L. M., Cannazza, G., Su, K.-P., Pariante, C. M., & Zunszain, P. A. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.05.006 · Cited by 126
Aryl hydrocarbon receptor mediates both proinflammatory and anti‐inflammatory effects in lipopolysaccharide‐activated microglia
Lee, Y., Lin, C., Hsu, P.-C., Sun, Y., Huang, Y., Zhuo, J., Wang, C., Gan, Y., Hung, C., Kuan, C.-Y., et al. (2015) · Glia · doi:10.1002/glia.22805 · Cited by 126
Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study
Chouraki, V. A., Preis, S. R., Yang, Q., Beiser, A., Li, S., Larson, M. G., Weinstein, G., Wang, T. J., Gerszten, R. E., Vasan, R. S., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.04.009 · Cited by 126
Nutrition and the ageing brain: Moving towards clinical applications
Flanagan, E. C., Lamport, D. J., Brennan, L., Burnet, P. W. J., Calabrese, V., Cunnane, S. C., de Wilde, M. C., Dye, L., Farrimond, J. A., Lombardo, N. B. E., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101079 · Cited by 132
Systemic tryptophan homeostasis
Klaessens, S., Stroobant, V., Plaen, E. D., & den Eynde, B. J. V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.897929 · Cited by 127
Molecular mechanisms underlying physical exercise-induced brain BDNF overproduction
Cefis, M., Chaney, R., Wirtz, J., Méloux, A., Quirié, A., Leger, C., Prigent‐Tessier, A., & Garnier, P. E. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1275924 · Cited by 145
Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
Parrott, J. M., & O’Connor, J. C. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00116 · Cited by 125
Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease
Stärkel, P., Leclercq, S., de Timary, P., & Schnabl, B. (2018) · Clinical Science · doi:10.1042/cs20171055 · Cited by 127
3-Hydroxykynurenine: An intriguing molecule exerting dual actions in the Central Nervous System
Colín-González, A. L., Maldonado, P. D., & Santamarı́a, A. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.11.007 · Cited by 121
Microglia in neurodegenerative diseases
Xu, Y., Jin, M.-Z., Yang, Z., & Jin, M.-Z. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.290881 · Cited by 121
Gut microbiota-derived vitamins – underrated powers of a multipotent ally in psychiatric health and disease
Rudzki, L., Stone, T. W., Maes, M. H. J., Misiak, B., Samochowiec, J., & Szulc, A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110240 · Cited by 125
The homeostatic astroglia emerges from evolutionary specialization of neural cells
Verkhratsky, A., & Nedergaard, M. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0428 · Cited by 133
Imbalanced Kynurenine Pathway in Schizophrenia
Kegel, M. E., Bhat, M., Skogh, E., Samuelsson, M., Lundberg, K., Dahl, M., Sellgren, C. M., Schwieler, L., Engberg, G., Schuppe‐Koistinen, I., et al. (2014) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s16800 · Cited by 122
Cholinergic connectivity: it's implications for psychiatric disorders
Scarr, E., Gibbons, A. S., Neo, J. H., Udawela, M., & Dean, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00055 · Cited by 124
Microbiota, immunoregulatory old friends and psychiatric disorders
Rook, G. A. W., Raison, C. L., & Lowry, C. A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_15 · Cited by 117
Does kynurenic acid act on nicotinic receptors? An assessment of the evidence
Stone, T. W. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14907 · Cited by 123
Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia
Fazio, F., Lionetto, L., Curto, M., Iacovelli, L., Cavallari, M., Zappulla, C., Ulivieri, M., Napoletano, F., Capi, M., Corigliano, V., et al. (2015) · Scientific Reports · doi:10.1038/srep17799 · Cited by 119
Changes in kynurenine pathway metabolism in Parkinson patients with L‐ DOPA ‐induced dyskinesia
Havelund, J. F., Andersen, A. D., Binzer, M., Blaabjerg, M., Heegaard, N. H. H., Stenager, E., Færgeman, N. J., & Gramsbergen, J. B. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14104 · Cited by 115
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
Jung, E. S., Choi, H., & Mook-Jung, I. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00825-0 · Cited by 124
Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans
Yan, E., Frugier, T., Lim, C. K., Heng, B., Sundaram, G., Tan, M., Rosenfeld, J. V., Walker, D. W., Guillemin, G., & Morganti-Kossmann, M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0328-2 · Cited by 96
Targeting of NMDA receptors in new treatments for schizophrenia
Hashimoto, K. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.934225 · Cited by 117
The kynurenine pathway in major depression: What we know and where to next
Brown, S. J., Huang, X., & Newell, K. A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.018 · Cited by 119
Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory
Heisler, J. M., & O’Connor, J. C. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.022 · Cited by 117
Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine Pathway
Küster, O. C., Laptinskaya, D., Fissler, P., Schnack, C., Zügel, M., Nold, V., Thurm, F., Pleiner, S., Karabatsiakis, A., von Einem, B., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170447 · Cited by 122
Muscle-to-Brain Signaling Via Myokines and Myometabolites
Rai, M., & Demontis, F. (2022) · Brain Plasticity · doi:10.3233/bpl-210133 · Cited by 126
Sex-specific effects of docosahexaenoic acid (DHA) on the microbiome and behavior of socially-isolated mice
Davis, D. J., Hecht, P. M., Jasarevic, E., Beversdorf, D. Q., Will, M. J., Fritsche, K., & Gillespie, C. H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.09.003 · Cited by 112
Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge
Parrott, J. M., Redus, L., & O’Connor, J. C. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0590-y · Cited by 112
Kynurenine pathway in Parkinson's disease—An update
Venkatesan, D., Iyer, M., Narayanasamy, A., Siva, K., & Vellingiri, B. (2020) · eNeurologicalSci · doi:10.1016/j.ensci.2020.100270 · Cited by 121
Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia
Haroon, E., Chen, X., Li, Z., Patel, T., Woolwine, B. J., Hu, X. P., Felger, J. C., & Miller, A. H. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0241-4 · Cited by 117
Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings
Scaini, G., Valvassori, S. S., Díaz, A. P., Lima, C. N. D. C., Benevenuto, D., Fries, G. R., & Quevedo, J. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0732 · Cited by 119
The role of the gut microbiome in the development of schizophrenia
Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G. A., & Dinan, T. G. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.010 · Cited by 121
Kynurenine regulates NLRP2 inflammasome in astrocytes and its implications in depression
Zhang, Q., Sun, Y., He, Z., Xu, Y. X., Li, X., Ding, J., Lu, M., & Hu, G. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.016 · Cited by 111
The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression
Lavebratt, C., Olsson, S., Backlund, L., Frisén, L., Sellgren, C. M., Priebe, L., Nikamo, P., Träskman‐Bendz, L., Cichon, S., Vawter, M. P., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.11 · Cited by 109
Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine
Molteni, R., Macchi, F., Zecchillo, C., Dell’Agli, M., Colombo, E., Calabrese, F., Guidotti, G., Racagni, G., & Riva, M. A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.008 · Cited by 106
A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder
Sellgren, C. M., Kegel, M. E., Bergen, S. E., Ekman, C. J., Olsson, S., Larsson, M. K., Vawter, M. P., Backlund, L., Sullivan, P. F., Sklar, P. B., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.186 · Cited by 107

Authors: Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q.
Affiliations: University of Maryland, Baltimore (US)
The Ohio State University (US)
University of California, San Francisco (US)
Corresponding author: Schwarcz, Robert
ORCID: Schwarcz, Robert
Bruno, John P.
Wu, Hui-Qiu
Venue: Nature Reviews Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2012-06-08
Volume: 13
Issue: 7
Pages: 465-477
ISSN: 1471-003X (ISSN-L)
1471-0048
DOI: 10.1038/nrn3257
PMC: PMC3681811
OpenAlex: W2060050678
Cited by: 1,530
References: 215
Citations by year: 2026: 157 · 2025: 137 · 2024: 124 · 2023: 98 · 2022: 118 · 2021: 145 · 2020: 132 · 2019: 95 · 2018: 83 · 2017: 96 · 2016: 98 · 2015: 105 · 2014: 64 · 2013: 63 · 2012: 13
FWCI: 5.11
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Neuroscience (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Mental Health (R01MH083729)
National Institute of Neurological Disorders and Stroke (R01NS057715)
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: kynurenine pathway, tryptophan metabolism, kynurenic acid, 3-hydroxykynurenine, quinolinic acid, neuroactive metabolites, neurodegenerative diseases, depression, schizophrenia, therapeutic targeting
MeSH terms: Animals, Brain, Humans, Kynurenine, Nervous System Diseases, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Kynurenines in the mammalian brain: when physiology meets pathology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks